Patients with AD exhibit elevated levels of peripheral immune cells and pro-inflammatory cytokines—such as interleukin-6 (IL-6), IL-17, and tumor necrosis factor-α (TNF-α)—in both cerebrospinal fluid(CSF) and peripheral blood (63). Here, IL6 is linked to Alzheimer disease.